19340-26-2 Usage
Uses
Used in Pharmaceutical Synthesis:
2,3,5,6-Tetrachloropyridine-4-carboxylic acid serves as an intermediate in the production of pharmaceuticals, contributing to the development of new drugs due to its unique structural properties and reactivity.
Used in Agrochemical Production:
In the agrochemical industry, 2,3,5,6-Tetrachloropyridine-4-carboxylic acid is utilized as a key intermediate, playing a crucial role in the synthesis of various agrochemicals that aid in crop protection and enhancement of agricultural yields.
Used in Organic Compounds Synthesis:
This chlorinated pyridine derivative is employed as a versatile building block in the synthesis of a range of organic compounds, leveraging its chemical reactivity and structural features to create diverse molecules for various applications.
Used in Dye Synthesis:
2,3,5,6-Tetrachloropyridine-4-carboxylic acid is also used as a starting material in the synthesis of dyes, where its chlorinated structure imparts specific color characteristics and properties to the resulting dye products.
Used in Specialty Chemicals Production:
2,3,5,6-Tetrachloropyridine-4-carboxylic acid finds application in the creation of specialty chemicals, where its unique attributes are harnessed to produce chemicals with specific functionalities required in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 19340-26-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,3,4 and 0 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 19340-26:
(7*1)+(6*9)+(5*3)+(4*4)+(3*0)+(2*2)+(1*6)=102
102 % 10 = 2
So 19340-26-2 is a valid CAS Registry Number.
InChI:InChI=1/C6HCl4NO2/c7-2-1(6(12)13)3(8)5(10)11-4(2)9/h(H,12,13)
19340-26-2Relevant academic research and scientific papers
DEUTERATED COMPOUNDS FOR TREATING FABRY, GAUCHER, PARKINSON'S AND RELATED DISEASES AND CONDITIONS, AND COMPOSITIONS AND METHODS THEREOF
-
Paragraph 0075; 0076, (2019/08/26)
Novel deuterium-containing chemical compounds are provided. They are glucosylceramide (GSC) synthase inhibitors and are useful for treating various types of lysosomal storage diseases including Fabry's disease, Gaucher's disease and Parkinson's disease, or related diseases and conditions. Also described are pharmaceutical compositions, and methods of preparation and use thereof.
